GOP senators raise concerns over potential deal to lower drug prices

9 July 2019 - Republican Senators and Trump administration officials met Tuesday morning to debate a potential deal to lower ...

Read more →

Why disclosing drug prices in TV ads won't lower costs

10 July 2019 - A federal judge blocked President Donald Trump’s order to force drugmakers to disclose the list prices ...

Read more →

Drug makers boost prices up to 909%, defying political pressure

10 July 2019 - Bipartisan efforts to lower drug prices in Washington have not prevented drugmakers from going about their ...

Read more →

CMS’s international pricing model for Medicare Part B drugs: implementation issues

9 July 2019 - For many years, Americans have paid significantly more than the rest of the world for prescription drugs. ...

Read more →

Trump rule requiring drug prices in TV ads blocked

8 July 2019 - Federal judge sides with companies, saying regulation would violate free speech. ...

Read more →

Speaker Pelosi, seize the moment to make history on drug pricing

8 July 2019 - House Speaker Nancy Pelosi has spent her entire life immersed in the Democratic Party, so she ...

Read more →

Sound, fury and prescription drugs

6 July 2019 - Despite talk of reform, drug prices keep climbing. Here’s how to change that. ...

Read more →

Trump suggests executive order on drug prices, with a scope that is unclear

5 July 2019 - He may be talking about a pilot program that would apply to only a small subset of ...

Read more →

Trump's bully pulpit didn’t stop drug price hikes

3 July 2019 - Pharmaceutical companies are raising prices again, and it will take more than a presidential tweet storm to ...

Read more →

Karyopharm Therapeutics prices blood cancer treatment after FDA approval

4 July 2019 - Karyopharm Therapeutics has set a list-price for its blood cancer treatment Xpovio at $22,000 per month, ...

Read more →

Trump fixates on drug prices as campaign looms

2 July 2019 - President Trump was apoplectic about drug prices once again.  ...

Read more →

Some insurers are pushing back on the high price for a Novartis gene therapy

3 July 2019 - Barely a month after Novartis won U.S. regulatory approval for its gene therapy — the most ...

Read more →

Gefitinib in new exchange group

28 June 2019 - As of June, gefitinib is included as an exchange group on the list of period goods. ...

Read more →

Will transparent pricing make America’s health care cheaper?

29 June 2019 - A new executive order requires hospitals and insurers to disclose their negotiated prices. ...

Read more →

Trump advisers pursue Democratic drug price ideas as campaign looms

2 July 2019 - President Trump was apoplectic about drug prices once again.  ...

Read more →